Ardent Health Inc.

ARDT • Medical - Care Facilities

$10.91

▲ +0.15 (+1.39%)

Current price

EarningsLatest report: Jun 30, 2026

BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.

Market Cap

$1.55B

Growth

12.1%

Cash Flow

4/5

Trend

Mostly stable

Evidence

Positive revenue growth · 7.2%Positive free cash flow · 1.84Consistent free cash flow · 4/5Reasonable earnings multiple · 9.15Healthy liquidity · 1.97

Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:12 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$10.91

Change1.39%

Shares Out142.41M

Market Cap$1.55B

Enterprise Value$1.93B

52W Range7.71 - 15.48

Beta0.70

P/E16.18

P/S0.24

P/B1.15

P/FCF10.90

EV/Sales0.30

Price$10.91

Change1.39%

Shares Out142.41M

Market Cap$1.55B

Enterprise Value$1.93B

52W Range7.71 - 15.48

Beta0.70

P/E16.18

P/S0.24

P/B1.15

P/FCF10.90

EV/Sales0.30

EV/EBITDA4.56

EV/FCF13.55

Earnings Yield6.18%

FCF Yield9.17%

Dividend Yield0.00%

Gross Margin97.54%

Oper. Margin5.15%

Profit Margin2.15%

Debt/Eq1.34

Current Ratio1.97

Quick Ratio1.85

Revenue 5Y12.05%

FCF 5Y20.75%

Target$13.33

Target Upside22.18%

Target Median$13.00

Target Range13.00 - 14.00

Volume259.69K

Avg Volume508.54K

EPS Surprise0.10

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

27/100

Financial Strength

Debt, cash, stability

77/100

Growth Potential

Revenue and expansion

88/100

Price Attractiveness

Cheap or expensive today

94/100

Why this score▼

Positive revenue growth · 7.2%Positive free cash flow · 1.84Consistent free cash flow · 4/5Reasonable earnings multiple · 9.15Healthy liquidity · 1.97Weak profitability

Analyst view

Analyst sentiment and price target

ARDT

Analyst sentiment

Based on 12 analyst votes · 2026-09-05

79/100

Bullish

Hold

Bearish

Price Target

2026-08-12

Low

$13.00

Mean

$13.33

Median

$13.00

High

$14.00

Company Overview

IPO: 7/18/2024

Industry: Medical - Care Facilities

P/B i: 1.15

Debt / Equity i: 1.34

Operating Margin: 5.15%

Net Margin: 2.15%

ROE i: -

ROIC: -

Financial Health

Score15 / 20

Debt / Equity: 1.34

Current Ratio: 1.97

Quick Ratio: 1.85

Status: Good

Insider Transactions

Recent executive and insider activity

Caspers Dave

Transaction: 07/01/2026

BUY

Change

+103,653

Price

Not reported

Filing

07/02/2026

Type

BUY

LUMSDAINE ALFRED

Transaction: 06/05/2026

BUY

Change

+10,000

Price

$8.81

Filing

06/08/2026

Type

BUY

DeMichiei Robert

Transaction: 06/05/2026

BUY

Change

+11,260

Price

$8.73

Filing

06/08/2026

Type

BUY

Insider	Type	Change	Price	Transaction	Filing
Caspers Dave	BUY	+103,653	Not reported	07/01/2026	07/02/2026
LUMSDAINE ALFRED	BUY	+10,000	$8.81	06/05/2026	06/08/2026
DeMichiei Robert	BUY	+11,260	$8.73	06/05/2026	06/08/2026
Bonick Martin	SELL	-10,952	$8.67	04/01/2026	04/02/2026
LUMSDAINE ALFRED	SELL	-4,381	$8.67	04/01/2026	04/02/2026
Byers David Raynor	SELL	-924	$8.67	04/01/2026	04/02/2026
Petrovich Stephen C.	SELL	-1,808	$8.67	04/01/2026	04/02/2026
Caspers Dave	SELL	-2,684	$8.67	04/01/2026	04/02/2026
BYNOE PETER C B	BUY	+14,231	Not reported	04/01/2026	04/02/2026
Campion Suzanne	BUY	+14,231	Not reported	04/01/2026	04/02/2026
GOODYEAR WILLIAM M	BUY	+14,231	Not reported	04/01/2026	04/02/2026
DeMichiei Robert	BUY	+14,231	Not reported	04/01/2026	04/02/2026
Robinson Edmondo	BUY	+14,231	Not reported	04/01/2026	04/02/2026
Webb Robert Thomas	BUY	+14,231	Not reported	04/01/2026	04/02/2026
Sen Rahul	BUY	+14,231	Not reported	04/01/2026	04/02/2026
Sotir Mark R	BUY	+14,231	Not reported	04/01/2026	04/02/2026
Havdala Ellen	BUY	+14,231	Not reported	04/01/2026	04/02/2026
Bulgarelli Peter J.	BUY	+14,231	Not reported	04/01/2026	04/02/2026
Bonick Martin	SELL	-8,026	$8.56	03/31/2026	04/02/2026
LUMSDAINE ALFRED	SELL	-2,510	$8.56	03/31/2026	04/02/2026

About the Company

Ardent Health Inc.

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Source - link

Peers

ACHC ADUS ASTH AVAH BKD IBRX LFST MD NHC SEM

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Hsbc Holdings PLC Invests $543,000 in Ardent Health, Inc. $ARDT

Hsbc Holdings PLC bought a new position in Ardent Health, Inc. (NYSE: ARDT) during the quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 55,280 shares of the company's stock, valued at approximately $543,000. A number of other institutional investors and hedge

Defense World

Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine

BRENTWOOD, Tenn. & TYLER, Texas--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today marked a milestone in its East Texas partnership as UT Health East Texas expanded specialty care into the new UT Tyler School of Medicine Building in Tyler – the first time patient services and physician training share a single hub in the region. The building now houses UT Health East Texas women's health, pulmonary, orthope.

Business Wire

Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participate in the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, in Boston, Massachusetts. Members of the management team will participate in a fireside chat on September 9, 2026, at 11 a.m. ET. A live audio webcast of the event will be available in the Investor Relations sec.

Business Wire

Implied Volatility Surging for Ardent Health Stock Options

Investors need to pay close attention to ARDT stock based on the movements in the options market lately.

Zacks Investment Research

Oklahoma Heart Institute Brings New National Cardiovascular Trials and Technologies to Patients Across the Region

BRENTWOOD, Tenn. & TULSA, Okla.--(BUSINESS WIRE)--Oklahoma Heart Institute (OHI), part of Hillcrest HealthCare System and Ardent Health (NYSE: ARDT), is now the only site in Oklahoma and the surrounding region participating in several leading national cardiovascular trials – and recently became the first in the United States to use the next-generation Supira percutaneous left ventricular assist device (pVAD) as part of the SUPPORT II clinical trial. Through this research, OHI is expanding acces.

Business Wire

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-05-05	0.18	0.28	0.1
2026-03-04	0.348	0.32	-0.028
2025-11-12	0.424	0.52	0.096
2025-08-05	0.3	0.52	0.22
2025-05-06	0.21	0.29	0.08
2025-02-26	0.5	0.81	0.31
2024-11-06	0.3	0.17	-0.13
2024-08-14	0.3	0.34	0.04